3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Neuroendocrine Tumors
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Endometrial Cancer Recurrent
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms, Male
1
Interventions
Bevacizumab
3
ribociclib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Panobinostat
2
pembrolizumab
1
dipinacoline glutamate
1
dinutuximab
1
cemiplimab
1
adavosertib
1
abemaciclib
1
Vorinostat
1
Valproic Acid
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nivolumab
1
Maintenance
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Everolimus
1
Erlotinib Hydrochloride
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diffuse Intrinsic Pontine Glioma
×
TIC10 compound
×
Clear all
No trials found.